US FDA seeks WHO's support to explore innovation in vaccine trials
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has invited the World Health Organization to take charge of a project that will look at innovative approaches to designing vaccine trials and using pharmacovigilance tools to facilitate a more rapid introduction of new vaccines1.